Order Article Reprints

Kumagi T, Terao T, Kuroda T, Koizumi M, Imamura Y, Ohno Y, Yokota T, Azemoto N, Uesugi K, Kisaka Y, et al. Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate. Cancers. 2023; 15(3):561. https://doi.org/10.3390/cancers15030561

Kumagi, Teru, Takashi Terao, Taira Kuroda, Mitsuhito Koizumi, Yoshiki Imamura, Yoshinori Ohno, Tomoyuki Yokota, Nobuaki Azemoto, Kazuhiro Uesugi, Yoshiyasu Kisaka, and et al. 2023. "Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate" Cancers 15, no. 3: 561. https://doi.org/10.3390/cancers15030561

Kumagi, T., Terao, T., Kuroda, T., Koizumi, M., Imamura, Y., Ohno, Y., Yokota, T., Azemoto, N., Uesugi, K., Kisaka, Y., Tanaka, Y., Shibata, N., Miyata, H., Miyake, T., & Hiasa, Y., on behalf of the Ehime Pancreato-Cholangiology (EPOCH) Study Group. (2023). Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate. Cancers, 15(3), 561. https://doi.org/10.3390/cancers15030561